PMGC HOLDINGS INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PMGC HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.47M.
- PMGC HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $0.00.
- PMGC HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $7.04M.
- PMGC HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was -$25.24M.
- PMGC HOLDINGS INC. stock issued during period, value, new issues for fiscal 2024 was $7.04M.
- PMGC HOLDINGS INC. stock issued during period, value, new issues for fiscal 2023 was -$991.63K.
- PMGC HOLDINGS INC. stock issued during period, value, new issues for fiscal 2022 was -$33.13K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $1.47M 10-Q · filed 2025-08-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $7.04M 10-K · filed 2026-03-30 |
| 2024-09-30 | $7.04M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | -$991.63K 10-K · filed 2024-03-29 | |
| 2022-12-31 | -$33.13K 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$25.24M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |